GILD Stock Current Trading Information 05/03/2014 23:57:39

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday Gilead Sciences (GILD) $GILD opened at 79.32 hitting the high price of 79.50 and a day low of 76.65 with a total volume of 16,776,500. GILD had a previous close of 79.02 and has been seeing an average volume of 22,693,230.

Overall Average: 32% Buy

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Did This Lightning-Rod Drug Go Too Far?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat May 03, 2:12PM CDT
In this segment from  Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass discuss the continuing backlash from pharmacy benefits manager Express Scripts against the price point Gilead has set for its... (full story)

Final Glance: Biotechnology companies
AP - Fri May 02, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading: (full story)

BetterInvesting Magazine Releases July Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
PR Newswire - Fri May 02, 3:15PM CDT
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Gilead Sciences, Inc. (NDQ: GILD) as its July 2014 "Stock to Study" and Microsoft Corporation (NDQ: MSFT) as its July 2014 "Undervalued Stock" for investors' informational and educational use. (full story)

Loss at BioMarin Narrower Than Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 3:00PM CDT
Higher product sales narrowed first quarter loss at BioMarin (BMRN). (full story)

Shire Beats on Earnings in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 2:05PM CDT
Shire (SHPG) reported first quarter 2014 earnings (excluding special items and amortization) of $2.36 per American Depositary Share (ADS), up from $1.72 per ADS in the year-ago quarter and beating the Zacks Consensus Estimate of $2.22. (full story)

Affymetrix Q1 Earnings Beat Ests by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 1:50PM CDT
Affymetrix Inc. (AFFX) reaffirmed its previously announced revenue and EBITDA guidance for 2014. (full story)

Express Scripts Earnings: 3 Things You Need to Know
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
Express Scripts investors had a rough day Tuesday, as a surprised market cut 6% from the company's value after a disappointing first quarter earnings report. There were three huge areas of concern for investors, but first let's talk about the... (full story)

Midday Glance: Biotechnology companies
AP - Fri May 02, 12:30PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.: (full story)

Novo Nordisk Beats Earnings Ests, Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 10:10AM CDT
Novo Nordisk reported 1Q14 earnings of 45 cents per ADR, beating the Zacks Consensus Estimate of 44 cents (full story)

Wider-than-Expected Q1 Loss at Incyte - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 10:00AM CDT
Incyte's (INCY) loss of 21 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate of a loss of 19 cents. (full story)

Early Glance: Biotechnology companies
AP - Fri May 02, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.: (full story)

Biotech Sector Performance in April: Gilead Sciences Rising
at The Street - Fri May 02, 8:49AM CDT
The biotech sector was down again, but there's some hopeful signs of a recovery. (full story)

Can the Rally in Gilead (GILD) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 8:41AM CDT
Can the Rally in Gilead (GILD) Shares Continue? (full story)

Earnings Estimates Moving Higher for Gilead (GILD): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:58AM CDT
Gilead may be an interesting play for investors, as it is seeing solid activity on the earnings estimate revision front (full story)

Merrimack Pharmaceuticals, Inc. (MACK) Appears Robust as Stock Shoots up 59.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:44AM CDT
Merrimack Pharmaceuticals, Inc. (MACK) was a big mover last session, as the company saw its shares surge a whopping 59.2% on the day (full story)

Jim Cramer's 'Mad Money' Recap: Unsafe at Any Price
at The Street - Thu May 01, 7:00PM CDT
Big money managers are once again shifting direction, Cramer says. (full story)

Health Care Stocks Still Healthy Despite Higher Hedging Costs
at The Street - Fri May 02, 5:30AM CDT
Health care is still outperforming the overall indices -- mergers and stellar sales figures and all. Can it be sustained? (full story)

'Mad Money' Lightning Round: Buy, Buy, Buy Gilead Sciences
at The Street - Fri May 02, 5:00AM CDT
Cramer says don't buy Ensco International and Quidel, beware of Gogo but buy more Boeing. (full story)

Vertex ends hepatitis C investment as sales fall
AP - Thu May 01, 6:27PM CDT
NEW YORK (AP) — Vertex Pharmaceuticals, which reported more than $1 billion in sales of its hepatitis C drug Incivek in 2012, said Thursday it won't invest any more money on research and development of new treatments for the disease. (full story)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Microplastics Found in Human Blood: Alarming Evidence

Updated Category News Views 26

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Continue Reading
Golden Bear Faces Wage Violation Class Action Case

Updated Category News Views 94

Legal Battle Brewing in Merced Well, folks, looks like Golden Bear Physical Therapy Sports Injury Center, Inc. is in for a bumpy ride. The company is facing a whopper of a class action lawsuit, filed by the folks over at Blumenthal Nordrehaug Bhowmik De Blouw LLP, alleging violations of the California Labor Code. This legal skirmish is unfolding right there in the Merced...

Continue Reading
CoCo Expands Bubble Tea Empire: Hungary to Ukraine

Updated Category News Views 48

CoCo's Three-Market Strategy Dive into the world of bubbly enthusiasm: CoCo Bubble Tea is making a splash in Central and Eastern Europe, targeting Hungary, Armenia, and gearing up for Ukraine. No small feat, this move taps straight into the heart of younger consumers who can't get enough of quirky, customizable Asian-inspired drinks. We're not only talking tea—this is a...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 49

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading
Doximity Lawsuit: What Investors Need to Know Now

Updated Category News Views 0

Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...

Continue Reading
Ukraine's Satellite: A New Era of Sovereignty

Updated Category News Views 113

Ukraine's Bold Satellite Leap Alright, folks! Ukraine’s got a satellite cruising in orbit, and let me tell you, this ain't just some vanity space flight—it’s a downright pivotal shift in their communications game. Been a rough road to this milestone, but now we're seeing them break free from relying on foreign infrastructure for their satellite needs. What this...

Continue Reading
XCMG's Major Truck Deal Signals Bold Move in Zambia

Updated Category News Views 54

Revolutionizing Infrastructure with 500 Trucks When it comes to hauling heavy goods across stretching Zambian highways, who's stepping up to the plate? XCMG, that's who. October 27, 2026, will go down in the books as the day this Chinese construction juggernaut inked a deal to supply 500 on-highway trucks in Zambia. But it's not just another transaction—it’s a...

Continue Reading
3TREES Debuts Green Coatings to East African Market

Updated Category News Views 85

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...

Continue Reading
Advanced Process Solutions Reshuffles Leadership Amid Growth

Updated Category News Views 131

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

Continue Reading
Seeking Balance in Home Care Staffing: BVNA's Stand

Updated Category News Views 535

Time to Set the Record Straight: Why Home Care Deserves Our Attention Out here in Pittsfield, Massachusetts, there's a showdown brewing between the Berkshire Visiting Nurse Association (BVNA) and its dedicated crew—those frontline warriors delivering care where it's most personal, right at home. Picture this: a petition lands squarely on the management's desk at 4 p.m....

Continue Reading

Top 5 Most Recently Viewed Articles

FEI-Zyfer Secures Significant $3.14 Million Defense Contract

Updated Category News Views 157

FEI-Zyfer Secures Major Contract FEI-Zyfer, Inc., a wholly-owned subsidiary of Frequency Electronics, Inc. (NASDAQ: FEIM), has announced a significant contract awarded by the Defense Logistics Agency's Aviation Division. This contract, valued at $3.14 million, is intended to support the advanced capabilities of the Patriot Missile system. Details of the Contract The...

Continue Reading
Introducing Andrew Jeffers: New Chief Customer Officer of CompQsoft Digital

Updated Category News Views 258

Andrew Jeffers Steps Into Role of Chief Customer Officer CompQsoft Digital, a global leader in Microsoft solutions and services, has announced a significant leadership change with the appointment of Andrew Jeffers as Chief Customer Officer (CCO). In this strategic new role, Andrew aims to lead customer success initiatives, oversee enterprise-scale digital transformations,...

Continue Reading
Capitol Federal Financial to Share Annual Meeting Presentation

Updated Category News Views 113

Capitol Federal Financial, Inc. Announces Annual Meeting Presentation Capitol Federal Financial, Inc. (NASDAQ: CFFN) is set to share the slide presentation for its upcoming annual meeting of stockholders. This meeting is scheduled to take place at 10:00 a.m. central time on a specified date, and the presentation will be available on its website. This is an important event...

Continue Reading
Exploring 10 Years of Growth for Alnylam Pharmaceuticals

Updated Category News Views 151

Transformative Growth of Alnylam Pharmaceuticals Alnylam Pharmaceuticals has made considerable strides over the past decade. Not only has the company shown remarkable growth, but it has also outperformed broader market trends. Over the last ten years, the company has achieved an impressive average annual return of 14.61%, which is 2.77% above market performance. The Value...

Continue Reading
Centerspace to Host Third Quarter Earnings Conference Call

Updated Category News Views 56

Centerspace's Upcoming Earnings Report and Call Centerspace (NYSE: CSR) is gearing up to announce its operating results for the recently concluded quarter. This occasion represents an important milestone for the company, which has built a reputation for commitment to excellence in the housing market. The earnings will reflect the operational status as of September 30,...

Continue Reading